These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 7972005

  • 1. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
    Farese RV, Standaert ML, Yamada K, Huang LC, Zhang C, Cooper DR, Wang Z, Yang Y, Suzuki S, Toyota T.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):11040-4. PubMed ID: 7972005
    [Abstract] [Full Text] [Related]

  • 2. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML, Soulage CO.
    Biochimie; 2013 Oct 08; 95(10):1811-27. PubMed ID: 23764390
    [Abstract] [Full Text] [Related]

  • 3. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats.
    Begum N, Ragolia L.
    Metabolism; 1998 Jan 08; 47(1):54-62. PubMed ID: 9440478
    [Abstract] [Full Text] [Related]

  • 4. Insulin activates glycerol-3-phosphate acyltransferase (de novo phosphatidic acid synthesis) through a phospholipid-derived mediator. Apparent involvement of Gi alpha and activation of a phospholipase C.
    Vila MC, Milligan G, Standaert ML, Farese RV.
    Biochemistry; 1990 Sep 18; 29(37):8735-40. PubMed ID: 2176832
    [Abstract] [Full Text] [Related]

  • 5. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
    Asplin I, Galasko G, Larner J.
    Proc Natl Acad Sci U S A; 1993 Jul 01; 90(13):5924-8. PubMed ID: 8392181
    [Abstract] [Full Text] [Related]

  • 6. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML.
    Diabetes Nutr Metab; 2001 Oct 01; 14(5):239-44. PubMed ID: 11806463
    [Abstract] [Full Text] [Related]

  • 7. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis.
    Avignon A, Yamada K, Zhou X, Spencer B, Cardona O, Saba-Siddique S, Galloway L, Standaert ML, Farese RV.
    Diabetes; 1996 Oct 01; 45(10):1396-404. PubMed ID: 8826977
    [Abstract] [Full Text] [Related]

  • 8. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
    Sun TH, Heimark DB, Nguygen T, Nadler JL, Larner J.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):1092-8. PubMed ID: 12051772
    [Abstract] [Full Text] [Related]

  • 9. Insulin rapidly increases glycerol-3-phosphate-acyltransferase activity in rat adipocytes.
    Vila MC, Farese RV.
    Arch Biochem Biophys; 1991 Feb 01; 284(2):366-8. PubMed ID: 1846521
    [Abstract] [Full Text] [Related]

  • 10. In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat.
    Pak Y, Hong Y, Kim S, Piccariello T, Farese RV, Larner J.
    Mol Cells; 1998 Jun 30; 8(3):301-9. PubMed ID: 9666467
    [Abstract] [Full Text] [Related]

  • 11. Thiazolidinedione treatment enhances insulin effects on protein kinase C-zeta /lambda activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats.
    Kanoh Y, Bandyopadhyay G, Sajan MP, Standaert ML, Farese RV.
    J Biol Chem; 2000 Jun 02; 275(22):16690-6. PubMed ID: 10749857
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
    Kanoh Y, Bandyopadhyay G, Sajan MP, Standaert ML, Farese RV.
    Endocrinology; 2001 Apr 02; 142(4):1595-605. PubMed ID: 11250941
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolation of insulin-sensitive phosphatidylinositol-glycan from rat adipocytes. Its impaired breakdown in the streptozotocin-diabetic rat.
    Macaulay SL, Larkins RG.
    Biochem J; 1990 Oct 15; 271(2):427-35. PubMed ID: 2173562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.
    Ueda K, Tanizawa Y, Ishihara H, Kizuki N, Ohta Y, Matsutani A, Oka Y.
    Diabetologia; 1998 Jun 15; 41(6):649-53. PubMed ID: 9662045
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
    Elased KM, Gumaa KA, de Souza JB, Rahmoune H, Playfair JH, Rademacher TW.
    Mol Genet Metab; 2001 Jul 15; 73(3):248-58. PubMed ID: 11461192
    [Abstract] [Full Text] [Related]

  • 19. Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.
    Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE.
    Metab Syndr Relat Disord; 2010 Apr 15; 8(2):127-36. PubMed ID: 20156067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.